c-MET Positive Gastric Cancer
1 clinical trials · Condition
◉ Watch c-MET Positive Gastric Cancer
| Record | Firm | Date |
|---|---|---|
| A Pilot Study of Crizotinib in Patients With c-MET Positive Gastric Adenocarcinoma as a Third-line Chemotherapy (NCT02435108) | Samsung Medical Center | 2014-05-15 |
Track c-MET Positive Gastric Cancer automatically
Every clearance here is in the API, with alerts when new ones post.